Philip Ferrone, MD
Ophthalmology · Great Neck, NYNPI 1164535472
Payments from drug & device makers
Across 2,090 payments — averaging $2751.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$2.2M
- Regeneron$2.1M
- Bayer$900K
- Apellis Pharmaceuticals, Inc.$312K
- Eyepoint US, Inc.$180K
- Regeneron Healthcare Solutions, Inc.$23K
- plus $51K from 21 others
Across 7 payments — averaging $1440.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$6K
- Regeneron$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 190 | $2,152,614 |
| Regeneron | 1,224 | $2,133,023 |
| Bayer | 356 | $899,788 |
| Apellis Pharmaceuticals, Inc. | 92 | $311,639 |
| Eyepoint US, Inc. | 5 | $180,002 |
| Regeneron Healthcare Solutions, Inc. | 63 | $22,955 |
| Alcon | 13 | $19,110 |
| Novartis | 12 | $8,526 |
| F. Hoffmann-la Roche AG | 3 | $7,834 |
| Genentech USA, Inc. | 71 | $3,825 |
| Carl Zeiss Meditec, Inc. | 3 | $3,820 |
| AbbVie(2 entities) | 20 | $3,090 |
| Harrow Eye, LLC | 3 | $2,971 |
| Coherus Oncology, Inc. | 8 | $388 |
| Sandoz | 6 | $179 |
| Heidelberg Engineering, Inc. | 3 | $153 |
| Dompe US, Inc. | 1 | $120 |
| Aerie Pharmaceuticals, Inc. | 1 | $119 |
| ASD Specialty Healthcare, LLC | 1 | $105 |
| Biogen | 4 | $86 |
| Alimera Sciences, Inc. | 3 | $80 |
| Ocular Therapeutix, Inc. | 1 | $65 |
| Oculus Surgical Inc. | 2 | $61 |
| Astellas Pharma US Inc | 2 | $47 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $34 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Carl Zeiss Meditec AG | 1 | $17 |
How this compares
$5,750,678 in reported general payments places this provider in the 95th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Great Neck
- Jonathan JonischGreat Neck$1M
- Kenneth GrahamGreat Neck$959K
- David RheeGreat Neck$699K
- Brett RosenblattGreat Neck$676K
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
- Richard SpaideNew York$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.